Who we are

BraineHealth is a trailblazer in global healthcare, driven by US Patent 11,908,579 B2 and our AI diagnostics platform, Diagnosio.

Founded with a vision to transform medicine through 99% accurate inversion technology—born from a 2018 KTH thesis—we outperform competitors like Microsoft’s MAI-DxO.

Featured in USA News, BizWeekly and AP, our work has gained traction across 450+ outlets.

We’re here to lead the $500B AI healthcare market by 2032, inviting investors and partners to join us.

License the Patent to integrate our 99% accurate AI technology.

Contact Us to collaborate.